United Therapeutics (UTHR) Institutional Ownership
13F filers reported holding 23.2% of United Therapeutics (UTHR) shares as of Sep 30, 2026, across 478 filers.
- Held by 13F filers
- 23.2%
- Sep 30, 2026
- 13F filers
- 478
- quarter ended Sep 30, 2026
- 13F value
- $5.3B
- 9.9M shares
- Quarter's fund flow
- Mild distribution
- 49 new · 42 closed
Is the smart money (institutions and insiders) accumulating or distributing? One lagging input, not a buy signal.
| Date | Name | Role | Type | Shares | Price** | SEC filing |
|---|---|---|---|---|---|---|
| Nov 6, 2026 | ROTHBLATT MARTINE A | Chairperson & CEO | Acquired · Option exercise | 9,500 | $117.76 | ↗ |
| Nov 6, 2026 | ROTHBLATT MARTINE A | Chairperson & CEO | Disposed · Open-market sale | 109 | $560.79 | ↗ |
| Nov 6, 2026 | ROTHBLATT MARTINE A | Chairperson & CEO | Disposed · Open-market sale | 2,005 | $561.80 | ↗ |
| Nov 6, 2026 | ROTHBLATT MARTINE A | Chairperson & CEO | Disposed · Open-market sale | 1,136 | $562.87 | ↗ |
| Nov 6, 2026 | ROTHBLATT MARTINE A | Chairperson & CEO | Disposed · Open-market sale | 870 | $563.85 | ↗ |
| Nov 6, 2026 | ROTHBLATT MARTINE A | Chairperson & CEO | Disposed · Open-market sale | 1,776 | $564.99 | ↗ |
| Nov 6, 2026 | ROTHBLATT MARTINE A | Chairperson & CEO | Disposed · Open-market sale | 1,742 | $565.85 | ↗ |
| Nov 6, 2026 | ROTHBLATT MARTINE A | Chairperson & CEO | Disposed · Open-market sale | 1,021 | $566.83 | ↗ |
| Nov 6, 2026 | ROTHBLATT MARTINE A | Chairperson & CEO | Disposed · Open-market sale | 761 | $567.64 | ↗ |
| Nov 6, 2026 | ROTHBLATT MARTINE A | Chairperson & CEO | Disposed · Open-market sale | 80 | $568.68 | ↗ |
| Nov 6, 2026 | ROTHBLATT MARTINE A | Chairperson & CEO | Disposed · Option exercise | 9,500Stock Option | — | ↗ |
| Nov 5, 2026 | ROTHBLATT MARTINE A | Chairperson & CEO | Disposed · Open-market sale | 200 | $593.14 | ↗ |
| Nov 5, 2026 | ROTHBLATT MARTINE A | Chairperson & CEO | Disposed · Open-market sale | 280 | $594.51 | ↗ |
| Nov 5, 2026 | ROTHBLATT MARTINE A | Chairperson & CEO | Disposed · Open-market sale | 120 | $595.43 | ↗ |
| Nov 5, 2026 | ROTHBLATT MARTINE A | Chairperson & CEO | Disposed · Open-market sale | 306 | $596.71 | ↗ |
| Nov 5, 2026 | ROTHBLATT MARTINE A | Chairperson & CEO | Disposed · Open-market sale | 237 | $597.74 | ↗ |
| Nov 5, 2026 | ROTHBLATT MARTINE A | Chairperson & CEO | Disposed · Open-market sale | 167 | $598.74 | ↗ |
| Nov 5, 2026 | ROTHBLATT MARTINE A | Chairperson & CEO | Disposed · Open-market sale | 10 | $599.80 | ↗ |
| Nov 5, 2026 | ROTHBLATT MARTINE A | Chairperson & CEO | Disposed · Open-market sale | 560 | $601.11 | ↗ |
| Nov 5, 2026 | ROTHBLATT MARTINE A | Chairperson & CEO | Disposed · Open-market sale | 80 | $602.49 | ↗ |
* Holdings as reported for Sep 30, 2026, 49 days old; funds file up to 45 days after each quarter-end, so the newest complete quarter runs 45 to 135 days behind.
** A price of “—” marks an option exercise, RSU vest or a filing without a usable per-share price, not a $0 trade.
Common questions
How much of United Therapeutics do institutions hold?
13F filers reported holding 23.2% of United Therapeutics' shares as of Sep 30, 2026, across 478 filers.
How many 13F filers hold United Therapeutics?
United Therapeutics was held by 478 13F filers as of Sep 30, 2026.
Not investment advice.

